News
2h
GOBankingRates on MSNIf You Invested $500 in Baseball Cards 30 Years Ago, Would It Outperform the S&P 500?Collecting baseball cards is more of a hobby than a business for most Americans. But in some cases, investing in baseball cards can actually provide a handsome return, even outpacing the S&P ...
Canada Goose sees strong DTC rebound and margin strength, but faces China risks and wholesale declines. Read why GOOS stock ...
3h
InvestorsHub on MSNAs S&P 500 and Nasdaq Reach New Highs, What’s Next for Markets in the Second Half of 2025?The U.S. stock market is entering the second half of 2025 with significant momentum. After a volatile start to the year, ...
Canadian LPs offer better balance sheets and global potential vs. U.S. MSOs in cannabis investing. Find out why fundamentals ...
Dream Unlimited offers niche growth and dividend strength, but high volatility, debt, and underperformance limit long-term ...
2d
Investor's Business Daily on MSNAs S&P 500 And Nasdaq Notch All-Time Highs, What Will Markets Bring In The Last Half Of 2025? Here Are A Few Clues.Even the slightest whiff of trouble with future earnings could ruin the stock market's improved outlook. What investors need ...
Conor Cunningham, of Melius Research, is an “uber cruise bull.” Why he likes airlines, Booking.com, and Hyatt Hotels, too.
If the Loonie rises, this Canadian icon could take off. The post The Best Stock to Own if You Think the Loonie is About to Rise appeared first on The Motley Fool Canada.
US Job data data due out later today has stilled futures of Canada’s main stock index today Market Numbers (Futures) TSX : Up ( 0.05%) 26,869.66 TSXV: Up (2.52%) 751.85 DOW: Up (0.13%) 44,832.00 ...
3d
Zacks Investment Research on MSNBuy These 4 Stocks With Solid Sales Growth Amid Market UncertaintyMarkets began 2025 on a strong note but have since been gripped by heightened volatility due to the Trump administration’s tariff plans and geopolitical headwinds, which have resulted in uncertainty.
3d
Stocktwits on MSNSunshine Biopharma Stock Soars After Launch Of First Biosimilar In $10B Canadian Market: Retail Bulls Charge InRetail chatter around Sunshine Biopharma surged late Wednesday after the company introduced Niopeg, its first biosimilar drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results